Catherine Engelbert
Equibles does not estimate personal net worth.
Get an email with a short summary when Royalty Pharma plc publishes a filing, an earnings call transcript or a press release.
Get RPRX alertsAbout Catherine Engelbert
Catherine Engelbert is recorded as Board Member at Royalty Pharma plc (RPRX) since June 16, 2020 and Board Member at Mcdonalds Corp (MCD) since January 1, 2019. The newest filing on record that lists Catherine Engelbert as Board Member at Mcdonalds Corp (MCD) is dated April 8, 2021. Mcdonalds Corp is classified in the Restaurants industry within the Consumer Cyclical sector. Royalty Pharma plc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Mcdonalds Corp includes Stephen Easterbrook (CEO), Chris Kempczinski (Chairman), Mahrukh Hussain (General Counsel) and 7 others.
Affiliation history
-
Current
2020-06-16–present
-
Current
2019-01-01–present
Last confirmed April 8, 2021
-
Royalty Pharma plc (RPRX)
Proxy statement
CurrentStart not stated–present
Last confirmed April 10, 2026
Company network
Leadership on record at Mcdonalds Corp
- Stephen Easterbrook CEO
- Chris Kempczinski Chairman
- Mahrukh Hussain General Counsel
- Lauren B. Elting Chief Accounting Officer
- Amy E. Weaver Board Member
- Anthony G. Capuano Board Member
- Enrique Hernandez Board Member
- James D. Farley, Jr. Board Member
- Jennifer L. Taubert Board Member
- John Mulligan Board Member
Leadership on record at Royalty Pharma plc
- Pablo Legorreta CEO
- Vlad Coric CEO, Board Member
- Christopher Hite Chairman
- David Hodgson Chairman
- Gregory Norden CFO
- Terrance Coyne CFO
- Arthur McGivern General Counsel
- Arthur R. McGivern General Counsel
- Carole Ho Board Member
- Dr. Vlad Coric Board Member
Recent activity
No call appearances or filed executive changes recorded yet.